About the Institute
Defining the boundaries of governance, accountability, and traceability in healthcare AI.
Our Mission
To develop and publish governance frameworks, principles, and reference methodologies that enable the responsible use of artificial intelligence in healthcare, with patient safety, clinical accountability, and operational traceability as first-order requirements.
Our Vision
A healthcare ecosystem where artificial intelligence is deployed in ways that are clinically accountable, reproducible, and resilient—so that technological capability never outpaces responsibility to patients.
The Charter
Adopted on January 21st 2026 and updated February 6th 2026.
1. Preamble
Artificial intelligence is increasingly embedded in healthcare delivery, clinical decision support, operational workflows, and patient-facing systems. Unlike many other domains, failures in healthcare AI can result in direct patient harm, clinician liability, and systemic loss of trust.
The Institute for Responsible Healthcare AI (IRHAI) is established to address this reality by focusing on governance, accountability, and assessment of AI systems used in healthcare — with the patient as the immutable center of concern.
2. Purpose
The purpose of IRHAI is to:
- Develop Healthcare-Specific Standards Develop healthcare-specific standards, assessment methodologies, and reference frameworks for the responsible use of artificial intelligence in medicine.
- Promote Clinical Accountability Promote clinical accountability, patient safety, reproducibility, and traceability as foundational requirements for healthcare AI.
- Support Institutions Support healthcare institutions, clinicians, and policymakers in understanding and governing AI systems across their full lifecycle.
Foundational Principles (Summary)
Patient Primacy
Patient safety, outcomes, and dignity take precedence over technological capability or administrative efficiency.
Risk Follows the Clinician
Accountability remains with the clinician. AI systems must support clinical responsibility, not obscure or dilute it.
Stability Is Safety
In healthcare, predictable and reproducible behavior is a safety requirement. Deterministic decision pathways are required wherever AI influences clinical actions to ensure traceability and auditability.
Speed Requires Guardrails
Technological velocity must never outpace responsibility. Deployment requires rigorous validation and enforceable human oversight.
Institutional Trust Reflects Safety
Adoption rests on the consistent demonstration of safe, ethical, and equitable outcomes across the entire system lifecycle.
These principles are defined canonically in the “IRHAI Principles Explained” reference document and are summarized here for orientation.
Scope & Boundaries
IRHAI's governance frameworks apply to any system utilizing machine learning, large language models (LLMs), or autonomous decision logic within the following contexts:
Direct Clinical Decision Support (CDS)
Diagnostics, treatment planning, and prognostic modeling.
Healthcare Operations & Logistics
Resource allocation, patient flow optimization, and risk stratification.
Patient-Facing AI Interfaces
Triage bots, educational agents, and automated patient monitoring.
Explicit Non-Claims
Not a Regulatory Authority
IRHAI does not hold legal or statutory authority to "approve" or "ban" medical devices. We provide frameworks that supplement regulatory compliance (e.g., FDA, EMA).
Not a Clinical Practice Body
IRHAI does not issue medical advice or define clinical protocols. We define the governance surrounding the AI that delivers those protocols.
Not a Software Vendor
IRHAI does not develop, sell, or endorse specific AI products. We remain neutral to provide objective assessment standards.
Independence
"The credibility of governance rests on its independence from commercial pressure."
IRHAI is funded through multi-institutional grants and member dues designed to prevent any single entity from exerting undue influence on our framework development. All board members must provide annual conflict-of-interest disclosures, and technical reviewers are required to recuse themselves from assessments involving products or firms with which they have financial ties.
Comments
Post a Comment